<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gambi G</submitter><funding>Stanford Genome Technology Center</funding><funding>Alex&amp;apos;s Lemonade Stand Foundation for Childhood Cancer</funding><funding>St. Baldrick&amp;apos;s Foundation</funding><funding>Italian Association for Cancer Research</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Cancer Institute Division of Cancer Prevention</funding><funding>Hopkins Population Center, Johns Hopkins University</funding><funding>American-Italian Cancer Foundation</funding><pagination>42-60.e7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11934262</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>85(1)</volume><pubmed_abstract>Cancer progression involves genetic and epigenetic changes that disrupt chromatin 3D organization, affecting enhancer-promoter interactions and promoting growth. Here, we provide an integrative approach, combining chromatin conformation, accessibility, and transcription analysis, validated by in silico and CRISPR-interference screens, to identify relevant 3D topologies in pediatric T cell leukemia (T-ALL and ETP-ALL). We characterize 3D hubs as regulatory centers for oncogenes and disease markers, linking them to biological processes like cell division, inflammation, and stress response. Single-cell mapping reveals heterogeneous gene activation in discrete epigenetic clones, aiding in patient stratification for relapse risk after chemotherapy. Finally, we identify MYB as a 3D hub regulator</pubmed_abstract><journal>Molecular cell</journal><pubmed_title>3D chromatin hubs as regulatory units of identity and survival in human acute leukemia.</pubmed_title><pmcid>PMC11934262</pmcid><funding_grant_id>R01 CA266212</funding_grant_id><funding_grant_id>R01CA252239</funding_grant_id><funding_grant_id>P01CA229086</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>R01 CA140729</funding_grant_id><funding_grant_id>RO1CA298153</funding_grant_id><funding_grant_id>26533</funding_grant_id><funding_grant_id>R01 CA252239</funding_grant_id><funding_grant_id>R01 CA271455</funding_grant_id><funding_grant_id>R01CA271455</funding_grant_id><funding_grant_id>P01 CA229086</funding_grant_id><funding_grant_id>R01 CA298153</funding_grant_id><funding_grant_id>R01 CA228135</funding_grant_id><funding_grant_id>P30 CA016087</funding_grant_id><funding_grant_id>R01CA140729</funding_grant_id><funding_grant_id>R01CA266212</funding_grant_id><funding_grant_id>R01CA228135</funding_grant_id><funding_grant_id>R01CA260028</funding_grant_id><funding_grant_id>R01 CA260028</funding_grant_id><pubmed_authors>Apostolou E</pubmed_authors><pubmed_authors>Tan J</pubmed_authors><pubmed_authors>Boccalatte F</pubmed_authors><pubmed_authors>Aifantis I</pubmed_authors><pubmed_authors>Avrampou K</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Tsirigos A</pubmed_authors><pubmed_authors>Gambi G</pubmed_authors><pubmed_authors>Nadorp B</pubmed_authors><pubmed_authors>Rodriguez Hernaez J</pubmed_authors><pubmed_authors>Kentsis A</pubmed_authors><pubmed_authors>Polyzos A</pubmed_authors><pubmed_authors>Inghirami G</pubmed_authors></additional><is_claimable>false</is_claimable><name>3D chromatin hubs as regulatory units of identity and survival in human acute leukemia.</name><description>Cancer progression involves genetic and epigenetic changes that disrupt chromatin 3D organization, affecting enhancer-promoter interactions and promoting growth. Here, we provide an integrative approach, combining chromatin conformation, accessibility, and transcription analysis, validated by in silico and CRISPR-interference screens, to identify relevant 3D topologies in pediatric T cell leukemia (T-ALL and ETP-ALL). We characterize 3D hubs as regulatory centers for oncogenes and disease markers, linking them to biological processes like cell division, inflammation, and stress response. Single-cell mapping reveals heterogeneous gene activation in discrete epigenetic clones, aiding in patient stratification for relapse risk after chemotherapy. Finally, we identify MYB as a 3D hub regulator</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-06T19:56:38.042Z</modification><creation>2026-06-04T03:12:28.011Z</creation></dates><accession>S-EPMC11934262</accession><cross_references><pubmed>39719705</pubmed><doi>10.1016/j.molcel.2024.11.040</doi></cross_references></HashMap>